Clinical Trial Update: Busulfan (BU) Plus Fludarabine Vs Intravenous BU Plus Cyclophosphamide as Conditioning Regimens Prior Allogeneic Hematopoetic Stem Cells Transplant (HSCT) in AML [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing busulfan plus fludarabine versus intravenous busulfan plus cyclophosphamide as conditioning regimens before allogeneic hematopoietic s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Busulfan (BU) (busulfan)
• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Fludarabine (Fludarabine)

Snippet

Sponsor: Gruppo Italiano Trapianto di Midollo Osseo | Conditions: Acute Myeloid Leukemia (AML) | Phase 3 | Status: COMPLETED